Author:
Gubbels Jennifer AA,Claussen Nick,Kapur Arvinder K,Connor Joseph P,Patankar Manish S
Abstract
AbstractOvarian cancer is particularly insidious in nature. Its ability to go undetected until late stages coupled with its non-descript signs and symptoms make it the seventh leading cause of cancer related deaths in women. Additionally, the lack of sensitive diagnostic tools and resistance to widely accepted chemotherapy regimens make ovarian cancer devastating to patients and families and frustrating to medical practitioners and researchers. Here, we provide an in-depth review of the theories describing the origin of ovarian cancer, molecular factors that influence its growth and development, and standard methods for detection and treatment. Special emphasis is focused on interactions between ovarian tumors and the innate and adaptive immune system and attempts that are currently underway to devise novel immunotherapeutic approaches for the treatment of ovarian tumors.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,Oncology
Reference130 articles.
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008, 58: 71–96. 10.3322/CA.2007.0010
2. Friedlander ML: Prognostic factors in ovarian cancer. Semin Oncol 1998, 25: 305–314.
3. Permuth-Wey J, Sellers T: Epidemiology of ovarian cancer. Methods Mol Biol 2009, 472: 413–437. full_text
4. Lowe KA, Andersen MR, Urban N, Paley P, Dresher CW, Goff BA: The temporal stability of the Symptom Index among women at high-risk for ovarian cancer. Gynecol Oncol 2009, 114: 225–230. 10.1016/j.ygyno.2009.03.015
5. Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Dresher CW, Paley P, Urban N: Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer 2008, 113: 484–489. 10.1002/cncr.23577
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献